PS Ratio
N/A
22 min ago
Summary
- CDTX price to sales ratio is not available.
Performance
CDTX PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
CDTX PS Ratio Trends
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | - | +0.5% | +0.5% | - |
| 1 m1 month | - | -21.0% | -21.0% | - |
| 3 m3 months | - | +62.7% | +152.7% | - |
| 6 m6 months | - | +88.9% | +193.8% | - |
| ytdytd | - | -19.6% | -19.6% | - |
| 1 y1 year | - | +62.8% | +293.4% | - |
| 5 y5 years | - | -63.5% | +136.0% | - |
CDTX PS Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | ||||
| 3 m | 3-month | ||||
| 6 m | 6-month | 1.50 | 1.21 | ||
| 1 y | 1-year | 1.60 | 0.69 | ||
| 3 y | 3-year | 2.73 | 0.54 | ||
| 5 y | 5-year | 14.06 | 0.54 | ||
| alltime | all time | 14.06 | 0.54 |
Cidara Therapeutics PS Ratio History
| Date | Value |
|---|---|
| 2023 | 0.86(+1.2%) |
| 2022 | 0.85(-51.1%) |
| Date | Value |
|---|---|
| 2021 | 1.74(-76.6%) |
| 2020 | 7.44(+19.8%) |
| 2019 | 6.21 |
FAQ
- What is the all time high PS ratio for Cidara Therapeutics?
What is the all time high PS ratio for Cidara Therapeutics?
Cidara Therapeutics all-time high price to sales ratio is 14.06